Results 11 to 20 of about 690,699 (300)

Development of fi lm forming formulation and technology of polymeric fi lm coating on Indotril tablets

open access: yesZaporožskij Medicinskij Žurnal, 2013
Introduction. In previous researches we grounded expedience of «Indotril» tablets development; formulation and technology of "Indotril" tablet cores were developed.
L. I. Kucherenko
doaj   +1 more source

Lawsuits in context [PDF]

open access: yes, 2007
The study of Roman procedure has benefited enormously from the discovery of wooden tablets near Pompeii. They are variously referred to as 'the Murecine tablets' (after the Agro Murecine, their place of discovery), 'the Pompeian tablets' (after the ...
Metzger, E.
core   +1 more source

Concerns regarding tablet splitting: a systematic review

open access: yesBJGP Open, 2022
Background: Tablet splitting can provide dose flexibility and cost savings; however, pharmaceutical representatives typically discourage the practice. Aim: To identify and summarise all published concerns related to tablet splitting and to present the ...
Aanchal K Saran   +2 more
doaj   +1 more source

Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions

open access: yesInternational Journal of Pharmaceutics: X, 2020
Mini-tablets are solid dosage forms with increasing interest for pharmaceutical industry due to clinical and biopharmaceutical benefits. But technological aspects on mini-tableting are not fully investigated. Therefore, the impact of punch size and tableting pressure for industrially relevant excipients like microcrystalline cellulose, lactose, isomalt
Ard Lura   +3 more
openaire   +3 more sources

Comparison of the determination of a low-concentration active ingredient in pharmaceutical tablets by backscatter and transmission raman spectrometry [PDF]

open access: yes, 2012
A total of 383 tablets of a pharmaceutical product were analyzed by backscatter and transmission Raman spectrometry to determine the concentration of an active pharmaceutical ingredient (API), chlorpheniramine maleate, at the 2% m/m (4 mg) level.
Andrews, John   +5 more
core   +1 more source

Lubricant sensitivity in function of paddle movement in the forced feeder of a high-speed tablet press [PDF]

open access: yes, 2016
Context: The negative impact of magnesium stearate (MgSt) on the hardness of tablets is a well-known phenomenon, but the influence of paddle movement in the forced feeder on the lubricant effect during tablet compression is often neglected.
Peeters, Elisabeth   +3 more
core   +2 more sources

Keep taking the tablets? Assessing the use of tablet devices in learning and teaching activities in the Further Education sector [PDF]

open access: yesResearch in Learning Technology, 2014
This article summarises the methodology and outcomes of an interventionist/action research project to assess the benefits, and potential pitfalls, of the use of mobile devices in learning and teaching activities in a Further Education environment. A bank
Khristin Fabian, Donald MacLean
doaj   +1 more source

“Ghost tablet” husks excreted in feces in large bupropion XL overdose [PDF]

open access: yes, 2018
Background: Extended-release medications are widely prescribed across the spectrum of medical specialties; however, there is heterogeneity in how they are formulated.
Nanagas, Kristine   +2 more
core   +1 more source

Spectrophotometric determination of fluocortolone in tablets using 1,4-dihydrazinophthalazine [PDF]

open access: yesJournal of the Serbian Chemical Society, 2000
The proposed method for the determination of fluocortolone is based on the formation of a stable, yellow coloured hydrazone product with 1,4-dihydrazinophthalazine as the reagent.
Čudina Olivera   +3 more
doaj   +1 more source

3DP Printing of Oral Solid Formulations: A Systematic Review

open access: yesPharmaceutics, 2021
Three-dimensional (3D) printing is a recent technology, which gives the possibility to manufacture personalised dosage forms and it has a broad range of applications.
Chiara R. M. Brambilla   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy